Solcera
Sponsors
INFECTOPHARM Arzneimittel und Consilium GmbH, Infectopharm Arzneimittel GmbH
Conditions
Actinic KeratosisActinic keratosis
Phase 3
5% KOH Solution vs. Placebo and Diclofenac Gel for the Treatment of Actinic Keratosis
CompletedNCT04552327
Start: 2020-10-14End: 2023-01-24Updated: 2024-03-05
Prospective, multistage, two-arm, randomised, double-blind study on the efficacy and safety of treatment of mild to moderate actinic keratosis with a 5% potassium hydroxide solution versus placebo with different duration of treatment cycles
RecruitingCTIS2024-514277-21-00
Start: 2025-03-19Target: 630Updated: 2025-05-27